Zobrazeno 1 - 10
of 949
pro vyhledávání: '"High risk human papillomavirus"'
Autor:
Jun Wang, Godwin Imade, Alani S. Akanmu, Jonah Musa, Rose Anorlu, Yinan Zheng, Olga Garcia-Bedoya, Gloria I. Sanchez, Jerome Belinson, Kyeezu Kim, Mamoudou Maiga, Demirkan B. Gursel, Atiene S. Sagay, Folasade T. Ogunsola, Robert L. Murphy, Lifang Hou
Publikováno v:
Infectious Agents and Cancer, Vol 19, Iss 1, Pp 1-7 (2024)
Abstract Background Easy-to-use, rapid, scalable, high-throughput, and cost-effective HPV tests are urgently needed for low-resource settings. Atila Biosystems’ high-throughput, cost-effective, and clinically validated ScreenFire HPV Risk Stratific
Externí odkaz:
https://doaj.org/article/39966b3eabab4926a338b5b16827f6c3
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Primary screening for high-risk human papillomavirus (hrHPV) with cytological triage for women with non-16/18 hrHPV-positive status has become popular in China. However, cytology relies on the subjective judgment of pathologists,
Externí odkaz:
https://doaj.org/article/9b1d51a883034c7ab1e506309155e762
Publikováno v:
International Journal of Women's Health, Vol Volume 16, Pp 1765-1774 (2024)
Hua-Mei Liu,1 Fan Zhang,1 Heng-Yun Cai,1 Yu-Mei Lv,2 Meng-Yuan Pi1 1Department of Gynecology and Obstetrics, Xiangyang Hospital of Integrated Chinese and Western Medicine, Xiangyang, Hubei, 441004, People’s Republic of China; 2Department of Clinica
Externí odkaz:
https://doaj.org/article/9f249266396c4d5ea96fb48b6fcb32ea
Publikováno v:
Zhongguo quanke yixue, Vol 28, Iss 02, Pp 213-219 (2025)
Background Cervical cancer, a prevalent malignancy in women, has a well-established etiology and can be effectively prevented through standardized screening. The WHO recommends HPV testing as the primary method for cervical cancer screening. Understa
Externí odkaz:
https://doaj.org/article/457c07428d134a6d9870da7a63138983
Molecular detection of high-risk papillomaviruses and vaccination status in normal cytology in Congo
Autor:
Dorine Florence Luthera Ngombe Mouabata, Anicet Luc Magloire Boumba, Patrina Joseph Iloukou Mayakia, Norvi Rigobert Bienvenu Massengo, Ragive Parode Takale, Donatien Moukassa, Moulay Mustapha Ennaji
Publikováno v:
Вопросы вирусологии, Vol 69, Iss 4, Pp 301-308 (2024)
Objective: The aim of this study was to identify the molecular prevalence of high-risk HPV infection and the distribution of genotypes present in normal cytology, as well as to determine the vaccination status of our study population. Methods: 110
Externí odkaz:
https://doaj.org/article/bda92e6053d64c6cb399456319173879
Publikováno v:
Zhenduanxue lilun yu shijian, Vol 23, Iss 04, Pp 416-423 (2024)
Objective To analyze the risk factors of persistent infection of high-risk human papillomavirus (HR-HPV) after cervical conization, so as to identify the high-risk population of residual and recurrent cervical lesions after cervical conization. Metho
Externí odkaz:
https://doaj.org/article/e0d77d5b918d4550a132ddab1c2ae652
Autor:
Xiaojing Chen, Xitong Jin, Linghua Kong, Yuligh Liou, Pei Liu, Zhe Dong, Sijun Zhou, Bingli Qi, Jing Fei, Xiaoyan Chen, Guangwu Xiong, Yuchong Hu, Shikai Liu, Jianwei Zhou, Huafeng Shou, Lei Li
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-9 (2024)
Abstract Objectives In this study, we aimed to validate the performance of the PAX1 and JAM3 methylation (PAX1 m /JAM3 m ) test as a triage tool for detecting cervical intraepithelial neoplasia grade 3 or worse (CIN3 +) in non-16/18 high-risk human p
Externí odkaz:
https://doaj.org/article/8f56218fac524721b3d2beb71c2ea58a
Autor:
Doaa Mahdy El-Wakil, Olfat G. Shaker, Ahmed S. S. A. Rashwan, Yasmine Fathy Elesawy, Nermin Samir
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-15 (2024)
Abstract Background Nitric oxide (NO) may contribute to the persistence of high-risk human papillomavirus (hrHPV) infection, which has been linked to the development of premalignant lesions and cervical cancer. Our study aimed to examine the relation
Externí odkaz:
https://doaj.org/article/6747da16387e45468ce8ea9003256790
The characteristics of high-risk HPV-negative cervical cancer: a systematic review and meta-analysis
Autor:
Jicheng Lou, Feng Guo
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionIn order to comprehensive understanding of the characteristics of high-risk HPV-negative cervical cancer and aiming to provide certain evidence in the diagnosis and treatment of this kind of disease, the clinical and pathological characte
Externí odkaz:
https://doaj.org/article/a8f00d4e61fc4d8daf0824c75ad95e04
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract In January 2020, a different cervical cancer screening program started in Germany. Women above the age of 35 are recommended to have a combined HPV and cytology swab every three years. Showing persistent high-risk human papillomavirus (hrHPV
Externí odkaz:
https://doaj.org/article/b75ba7f7a75448138fc439d1438946b6